Overview

Efficacy and Safety Study of Prucalopride for the Treatment of Chronic Constipation

Status:
Completed
Trial end date:
1997-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine which dose of prucalopride is safe and effective in patients with chronic constipation. Hypothesis: Prucalopride 1 and 2 mg bid are safe and effective for the treatment of chronic constipation whereas 0,5 mg is a suboptimal dose.
Phase:
Phase 2
Details
Lead Sponsor:
Movetis
Treatments:
Prucalopride